BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4858085)

  • 1. Delivery of anticonvulsant drug therapy in epileptic patients assessed by plasma level analyses.
    Wilson JT; Wilkinson GR
    Neurology; 1974 Jul; 24(7):614-23. PubMed ID: 4858085
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo interaction of anticonvulsant drugs. The mathematical correlation of plasma levels of anticonvulsant drugs in epileptic patients.
    Abarbanel J; Herishanu Y; Rosenberg P; Eylath U
    J Neurol; 1978 May; 218(2):137-44. PubMed ID: 78974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of plasma phenobarbital, diphenylhydantoin and primidone levels in epileptic patients.
    Watanabe S; Kuyama C; Yokoyama S; Kubo S; Iwai H
    Folia Psychiatr Neurol Jpn; 1977; 31(2):205-17. PubMed ID: 903037
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
    Farnbach GC
    J Am Vet Med Assoc; 1984 May; 184(9):1117-20. PubMed ID: 6725128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of epilepsy in the light of the determination of the anticonvulsant blood level].
    Majkowski J
    Neurol Neurochir Pol; 1971; 5(3):295-300. PubMed ID: 5116780
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.
    Yoshida T; Karahashi M; Tanabu M; Takagi T; Arakawa T
    Tohoku J Exp Med; 1974 Feb; 112(2):169-75. PubMed ID: 4836029
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
    Borst SI; Lockwood CH
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical study of serum primidone levels.
    Booker HE; Hosokowa K; Burdette RD; Darcey B
    Epilepsia; 1970 Dec; 11(4):395-402. PubMed ID: 5278206
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiepileptic drug concentrations in plasma. Clinical evaluation of 321 estimations in 237 unselected patients.
    Gardner-Thorpe C; Parsonage MJ; Smethurst PF; Toothill C
    Acta Neurol Scand; 1972; 48(2):213-21. PubMed ID: 5035960
    [No Abstract]   [Full Text] [Related]  

  • 10. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children.
    Buchanan RA; Allen RJ
    Neurology; 1971 Aug; 21(8):866-71. PubMed ID: 5106302
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of blood levels of antiepileptic drugs in clinical practice.
    Kutt H
    Pediatrics; 1974 Apr; 53(4):557-60. PubMed ID: 4595906
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of phenytoin on phenobarbitone and primidone metabolism.
    Lambie DG; Johnson RH
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):148-51. PubMed ID: 7217971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in response to anticonvulsants in a group of epileptic patients.
    Travers RD; Reynolds EH; Gallagher BB
    Arch Neurol; 1972 Jul; 27(1):29-33. PubMed ID: 4626104
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug interactions during anticonvulsant therapy in childhood: diphenylhydantoin, primidone, phenobarbitone, clonazepam, nitrazepam, carbamazepin and dipropylacetate.
    Windorfer A; Sauer W
    Neuropadiatrie; 1977 Feb; 8(1):29-41. PubMed ID: 321985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ethylphenacemide on serum levels of other anti-epileptic drugs.
    Huisman JW; van Heycop ten Ham MW; van Zijl CH
    Epilepsia; 1970 Jun; 11(2):207-15. PubMed ID: 5270551
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug.
    Windorfer A; Sauer W; Gädeke R
    Acta Paediatr Scand; 1975 Sep; 64(5):771-2. PubMed ID: 1101639
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationships between serum and cerebrospinal fluid anticonvulsant drug and folic acid concentrations in epileptic patients.
    Reynolds EH; Mattson RH; Gallagher BB
    Neurology; 1972 Aug; 22(8):841-4. PubMed ID: 4673411
    [No Abstract]   [Full Text] [Related]  

  • 18. [Special viewpoints in the treatment with anticonvulsants in childhood. Value of determination of serum level of anticonvulsants in the treatment of seizures].
    Windorfer A
    Fortschr Med; 1974 Oct; 92(28):1102-4. PubMed ID: 4457423
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report.
    Reynolds EH; Travers RD
    Br J Psychiatry; 1974 May; 124(0):440-5. PubMed ID: 4836373
    [No Abstract]   [Full Text] [Related]  

  • 20. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL; Bailey DG; Johnson GE; Wilson TW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.